Skip to main content

SABCS: CREATE-X – Capecitabine is efficacious against residual HER2-negative breast cancer

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
SABCS: CREATE-X – Capecitabine is efficacious against residual HER2-negative breast cancer

User login

Username

Password

Reset your password

Type	Lead	score